Ciprofloxacin

BreastfeedingGeriatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Agomelatine, Aminophylline, Amiodarone, Amitriptyline, Antacids, Antineoplastics, Arsenic, Artemether/Lumefantrine, BCG Vaccine, Bendamustine, Bepridil, Bismuth, Bismuth subsalicylate, Bretylium, Calcium salts, Citalopram, Clopidogrel, Clozapine, Corticosteroids, Cyclosporine, Dairy products, Dasatinib, Degarelix, Didanosine, Disopyramide, Dolasetron, Duloxetine, Dutasteride, Eluxadoline, Erlotinib, Erythromycin, Flibanserin, Insulin, Lanthanum, Lapatinib, Levofloxacin, Lumateperone, Magnesium salts, Meptazinol, Methotrexate, Methylxanthines, Mifepristone, Moxifloxacin, Mycophenolate, Neratinib, NSAIDs, Olanzapine, Olaparib, Opiod analgesics, Oral iron, Oxtriphylline, P-glycoprotein inhibitors, Pazopanib, Pentoxifylline, Phenothiazines, Phenytoin, Pirfenidone, Probenecid, Procainamide, Propranolol, QT prolonging agents, Quinapril, Quinidine, Rasagiline, Ropinirole, Ropivacaine, Sevelamer, Sotalol, St John's Wort, Strontium Ranelate, Sucralfate, Sulfonylureas, Telavancin, Telithromycin, Tizanidine, Tricyclic antidepressants, Typhoid Vaccine, Ubrogepant, Venetoclax, Vitamin K antagonists, Voriconazole, Vorinostat, Warfarin, Zinc, Ziprasidone, Zolmitriptan

PREGNANCY CATEGORY: C

Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants.

Fluoroquinolones may exacerbate muscle weakness in persons with myasthenia gravis.

Ciprofloxacin is chemically related to nalidixic acid.

SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRIAL NERVOUS SYSTEM EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS

See full prescribing information for complete boxed warning.

Our database has 172 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 03/25/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top